| http://www.w3.org/ns/prov#value | - LONDON, June 17, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (GW or the Company), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that it and certain of its shareholders intend to sell, subject to market and other conditions, 1.7 million American
|
